Comparison of mometasone furoate administered by metered dose inhaler with beclomethasone dipropionate

International Journal of Clinical Practice

Volumn 56, Issue 6, 2002, Pages 419-425

  Chervinsky, P ^a   Nelson, H S ^b   Bernstein, D I ^c   Berkowitz, R A ^d   Siegel, S C ^e  

^a New England Clinical Studies   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c Bernstein Allergy Group Inc   (United States)

^d Atlanta Allergy Clinic   (United States)

^e Allergy Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; FLUNISOLIDE; MOMETASONE FUROATE; PLACEBO; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXPIRATORY FLOW RATE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ASTHMA; BECLOMETHASONE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG DELIVERY SYSTEMS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PREGNADIENEDIOLS; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS;

EID: 0036336565     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Inhaled glucocorticoids for asthma
2. Asthma management and prevention: A practical guide for public health officials and health care professionals
3. A comparison of the efficacy and safety of inhaled corticosteroids in asthma
4. Efficacy and safety of inhaled corticosteroids: New developments
5. Adverse effects of inhaled corticosteroids
6. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics
7. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers
8. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids
9. Effects of budesonide by means of the Turbuhaler on the hypothalamic-pituitary-adrenal axis in asthmatic subjects: A dose-response study
10. Lack of systemic activity with intranasal mometasone furoate
11. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients
12. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray
13. Once-daily mometasone furoate aqueous nasal spray (Nasonex®) in seasonal allergic rhinitis: An active- and placebo-controlled study
14. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses
15. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
16. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma
17. Dose-ranging study of a new steroid for asthma: Mometasone furoate dry powder inhaler
18. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
19. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma
20. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma
21. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma
22. Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma
23. The Montreal Protocol on substances that deplete the ozone layer